ASX - Delayed Quote AUD

Wellnex Life Limited (WNX.AX)

0.0200 -0.0010 (-4.76%)
At close: 4:10 PM GMT+10
Loading Chart for WNX.AX
DELL
  • Previous Close 0.0210
  • Open 0.0210
  • Bid 0.0190 x --
  • Ask 0.0200 x --
  • Day's Range 0.0200 - 0.0210
  • 52 Week Range 0.0180 - 0.0516
  • Volume 451,734
  • Avg. Volume 978,827
  • Market Cap (intraday) 25.005M
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Mar 6, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Wellnex Life Limited develops health and wellness solutions in Australia. The company provides iron gummies under The Iron Company brand; natural energy products under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening products under Mr Bright brand; over-the-counter medicines under the Pharmacy Own brand; and pain relief product under the Wagner Liquigesics brand. In addition, the company offers organic baby skincare, aromatherapy essential oils, and domestic cleaning products, as well as provides provides contract manufacturing services. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is based in Port Melbourne, Australia.

wellnexlife.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Related News

Performance Overview: WNX.AX

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

WNX.AX
13.04%
S&P/ASX 200 [XJO]
1.21%

1-Year Return

WNX.AX
59.43%
S&P/ASX 200 [XJO]
4.93%

3-Year Return

WNX.AX
94.73%
S&P/ASX 200 [XJO]
8.81%

5-Year Return

WNX.AX
96.28%
S&P/ASX 200 [XJO]
20.38%

Compare To: WNX.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WNX.AX

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    25.01M

  • Enterprise Value

    32.75M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.56

  • Price/Book (mrq)

    3.84

  • Enterprise Value/Revenue

    1.61

  • Enterprise Value/EBITDA

    -1.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -95.45%

  • Return on Assets (ttm)

    -23.26%

  • Return on Equity (ttm)

    -269.74%

  • Revenue (ttm)

    20.31M

  • Net Income Avi to Common (ttm)

    -19.39M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    268k

  • Total Debt/Equity (mrq)

    123.00%

  • Levered Free Cash Flow (ttm)

    -12.39M

Company Insights: WNX.AX

People Also Watch